Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
New York DOH Approval Status
Indicates whether a test has been approved by the New York State Department of Health.
This test is New York state approved.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
Serum separator tube. Also acceptable: Lavender (K2 EDTA or K3 EDTA), pink (K2EDTA), or green (lithium heparin).
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Allow serum tube to sit for 15-20 minutes at room temperature for proper clot formation. Centrifuge and separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Frozen.
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Hemolyzed specimens.
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
After separation from cells: Ambient: 8 hours; Refrigerated: 72 hours; Frozen: 3 months
Methodology
Process(es) used to perform the test.
Quantitative Electrochemiluminescent Immunoassay
Performed
Days of the week the test is performed.
Tue-Sat
Reported
Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-4 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Age
Male
Female
6 months-6 years
39-121 ng/mL
44-130 ng/mL
7-9 years
66-182 ng/mL
73-206 ng/mL
10-12 years
85-232 ng/mL
77-262 ng/mL
13-15 years
70-336 ng/mL
33-222 ng/mL
16-17 years
43-237 ng/mL
24-99 ng/mL
18 years and older
8-36 ng/mL
8-36 ng/mL
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
In patients with renal failure, the osteocalcin result may be directly elevated, due to impaired clearance, and/or indirectly elevated due to renal osteodystrophy.
Compliance Category
FDA
Note
Additional information related to the test.
Hotline History
N/A
CPT Codes
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms.
BGLAP
bone gamma-carboxyglutamic acid-containing protein
N-MID osteocalcin
Osteocalcin
Osteocalcin (OCN)
Osteocalcin by Electrochemiluminescent Immunoassay
Connect Sign In
